pharmacare
2 stories
-
healthCanadian Gastrointestinal Society Criticizes BC's Slow Drug Approval Process
A leading Canadian health group is urging British Columbia to speed up approval for advanced inflammatory bowel disease treatments, citing outdated policies and potential harm to patients.
-
healthB.C. Stands Alone as Only Province Denying Life-Saving Drug Coverage
British Columbia remains the sole province not funding Luspatercept, a critical drug for MDS patients, despite its availability and life-changing impact elsewhere in Canada.